168 related articles for article (PubMed ID: 6673254)
1. A new method to give an antithrombogenicity to biological materials and its successful application to vascular grafts.
Miyata T; Noishiki Y; Matsumae M; Yamane Y
Trans Am Soc Artif Intern Organs; 1983; 29():363-8. PubMed ID: 6673254
[No Abstract] [Full Text] [Related]
2. A simple method to heparinize biological materials.
Noishiki Y; Miyata T
J Biomed Mater Res; 1986 Mar; 20(3):337-46. PubMed ID: 3957968
[TBL] [Abstract][Full Text] [Related]
3. Biologic and semibiologic vascular grafts.
Hansen OK; Kraft O; Mouritzen C
Surg Gynecol Obstet; 1974 Jun; 138(6):940-4. PubMed ID: 4275051
[No Abstract] [Full Text] [Related]
4. [Polymers modified by biologically active compounds--a new type of compatible material for contact with the blood].
Platé NA; Valuev LI; Chutov VV; Burdygina IF
Vopr Med Khim; 1985; 31(4):43-7. PubMed ID: 4049785
[TBL] [Abstract][Full Text] [Related]
5. [Surface-immobilized heparin prevents platelet coagulation].
Nystrand A
Lakartidningen; 1991 Jan; 88(4):237-40. PubMed ID: 1994172
[No Abstract] [Full Text] [Related]
6. Thermal and ionic methods of heparinizing small-diameter dacron grafts.
Hersh LS; Gott VL; Najjar F
J Biomed Mater Res; 1972; 6(4):85-96. PubMed ID: 5045266
[No Abstract] [Full Text] [Related]
7. Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response.
Hasegawa T; Okada K; Takano Y; Hiraishi Y; Okita Y
J Thorac Cardiovasc Surg; 2007 May; 133(5):1268-76, 1276.e1. PubMed ID: 17467440
[TBL] [Abstract][Full Text] [Related]
8. Some observations on the dielectric properties of cardiovascular implant materials.
Milligan HL; Cleminshaw WT; Edmark KW
J Biomed Mater Res; 1973 Sep; 7(5):445-70. PubMed ID: 4745792
[No Abstract] [Full Text] [Related]
9. Biocompatibie materials for use in the vascular system.
Grode GA; Falb RD; Crowley JP
J Biomed Mater Res; 1972; 6(4):77-84. PubMed ID: 5045265
[No Abstract] [Full Text] [Related]
10. Acceleration of neointima formation in vascular prostheses by transplantation of autologous venous tissue fragments. Application to small-diameter grafts.
Noishiki Y; Tomizawa Y; Yamane Y; Okoshi T; Satoh S; Matsumoto A
J Thorac Cardiovasc Surg; 1993 May; 105(5):796-804. PubMed ID: 8487559
[TBL] [Abstract][Full Text] [Related]
11. [Effect of complete hydration of expanded polytetrafluoroethylene graft on improved antithrombogenicity: an experimental study].
Higashidate M; Takanashi Y; Imai Y
Nihon Kyobu Geka Gakkai Zasshi; 1987 Jan; 35(1):13-9. PubMed ID: 3572117
[No Abstract] [Full Text] [Related]
12. The current status of in vivo screening of synthetic implant materials for blood compatibility.
Gott VL; Furuse A
Med Instrum; 1973; 7(2):121-4. PubMed ID: 4718485
[No Abstract] [Full Text] [Related]
13. A method to reduce thrombogenicity of a graft for small diameter arterial substitution seeded with autologous venous tissue fragments.
Noishiki Y; Yamane Y; Tomizawa Y; Okoshi T; Satoh S; Kosuge T; Ishii M; Ichikawa Y; Kajiwara H; Tomiyama I
ASAIO J; 1992; 38(3):M158-62. PubMed ID: 1457838
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of prosthetic vascular grafts using piezoelectric polymer sensors.
Dario P; Richardson PD; Galletti PM
Trans Am Soc Artif Intern Organs; 1983; 29():318-22. PubMed ID: 6673247
[No Abstract] [Full Text] [Related]
15. Thrombosis on prosthetic surfaces.
MacLean LD
Can J Surg; 1972 Nov; 15(6):333-4. PubMed ID: 5086556
[No Abstract] [Full Text] [Related]
16. Opportunities and responsibilities in the use of arterial grafts.
Sauvage LR
Surg Annu; 1984; 16():91-117. PubMed ID: 6233730
[No Abstract] [Full Text] [Related]
17. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
Mohamed MS; Mukherjee M; Kakkar VV
J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873
[TBL] [Abstract][Full Text] [Related]
18. Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts.
Meinhart J; Deutsch M; Zilla P
ASAIO J; 1997; 43(5):M515-21. PubMed ID: 9360096
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antithrombogenicity of polyetherurethaneurea containing quaternary ammonium groups in the side chains and of the polymer/heparin complex.
Ito Y; Sisido M; Imanishi Y
J Biomed Mater Res; 1986 Sep; 20(7):1017-33. PubMed ID: 3760001
[TBL] [Abstract][Full Text] [Related]
20. Stability of heparin S35 attached to a modified polyurethane vascular prosthetic.
Gardner DL; Sharp WV; Ewing KL; Finelli AF
Trans Am Soc Artif Intern Organs; 1969; 15():7-14. PubMed ID: 5791435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
